Format

Send to:

Choose Destination
See comment in PubMed Commons below
Expert Opin Med Diagn. 2013 Jan;7(1):5-16. doi: 10.1517/17530059.2012.709232. Epub 2012 Aug 17.

Advances in medical diagnosis of intra-amniotic infection.

Author information

  • 1Yale University, Department of Obstetrics, Gynecology & Reprod. Science, New Haven, CT 06520, USA. irina.buhimschi@yale.edu

Abstract

INTRODUCTION:

Intrauterine infection is a global problem and a significant contributor to morbidity and perinatal death. The host response to infection causes an inflammatory state that acts synergistically with microbial insult to induce preterm birth and fetal damage. Prompt and accurate diagnosis of intra-amniotic infection in the asymptomatic stage of the disease is critical for improved maternal and neonatal outcomes.

AREAS COVERED:

This article provides an overview of the most recent progress, challenges, and opportunities for discovery and clinical implementation of various maternal serum, cervicovaginal, and amniotic fluid biomarkers in pregnancies complicated by intra-amniotic infection.

EXPERT OPINION:

Clinically relevant biomarkers are critical to the accurate diagnostic of intrauterine infection. Front-end implementation of such biomarkers will also translate in lower incidence of early-onset neonatal sepsis (EONS) which is an important determinant of neonatal morbidity and mortality associated with prematurity. However, of the hundreds of differentially expressed proteins, only few may have clinical utility and thus function as biomarkers. The small number of validation studies along with barriers to implementation of technological innovations in the clinical setting are current limitations.

PMID:
23530840
[PubMed - indexed for MEDLINE]
PMCID:
PMC3790267
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Informa Healthcare Icon for PubMed Central
    Loading ...
    Write to the Help Desk